⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4456250 | 1.00 | — | — | |
| SCHEMBL49052 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL1334305 | 0.96 | — | — | |
| Ammonia Solution, Strong SCHEMBL20530704 | 0.96 | — | — | |
| Hydrochloric Acid SCHEMBL1076485 | 0.96 | — | — | |
| Hydrochloric Acid SCHEMBL1241497 | 0.96 | — | — | |
| Methyl Alcohol SCHEMBL11519103 | 0.93 | ESR2 (0.32) | — | |
| Methyl Alcohol SCHEMBL11189585 | 0.93 | ESR2 (0.32) | — | |
| SCHEMBL16248242 | 0.90 | — | — | |
| SCHEMBL5968011 | 0.90 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 680 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023249908-A1 | USE OF NON-TOXIC POLYAMINE ANALOGUES AND/OR INHIBITORS OF POLYAMINE BIOSYNTHESIS TO RE-BALANCE NATURAL POLYAMINE LEVELS IN SNYDER-ROBINSON SYNDROME AND RELATED DISORDERS | THE JOHNS HOPKINS UNIVERSITY (US) | 2023-12-28 | — | — | WO | claimed |
| WO-2022162525-A1 | A SYNERGISTIC ADMIXTURE FOR CORROSION INHIBITION OF REINFORCEMENT METALS AND ACCELERATION OF CONCRETE SETTING TIME | CONCHEM LABS LLP (IN) | 2022-08-04 | — | — | WO | claimed |
| US-20220142948-A1 | COMPOSITIONS AND METHODS FOR MODULATING METABOLIC REGULATORS OF T CELL PATHOGENICITY | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2022-05-12 | — | — | US | claimed |
| EP-3942023-A1 | COMPOSITIONS AND METHODS FOR MODULATING METABOLIC REGULATORS OF T CELL PATHOGENICITY | The Broad Institute, Inc. (US) | 2022-01-26 | — | — | EP | claimed |
| CN-109678726-B | Method for synthesizing trans-4-methylcyclohexylamine | 浙江清和新材料科技有限公司 | 2021-12-14 | — | — | CN | claimed |
| US-20210139610-A1 | COMPOSITIONS AND METHODS FOR MEDIATING EPS | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL (US) | 2021-05-13 | — | — | US | claimed |
| EP-3813811-A2 | COMPOSITIONS AND METHODS FOR MEDIATING EPS | Research Institute at Nationwide Children's Hospital (US) | 2021-05-05 | — | — | EP | claimed |
| CN-112672736-A | Compositions and methods for mediating EPS | 国家儿童医院研究所 | 2021-04-16 | — | — | CN | claimed |
| WO-2020191079-A1 | COMPOSITIONS AND METHODS FOR MODULATING METABOLIC REGULATORS OF T CELL PATHOGENICITY | THE BROAD INSTITUTE, INC. (US) | 2020-09-24 | — | — | WO | claimed |
| CN-109678726-A | A kind of method of synthesis of trans -4- methyl cyclohexylamine | 浙江清和新材料科技有限公司 | 2019-04-26 | — | — | CN | claimed |
| US-20040229886-A1 | Inhibitors of spermidine synthase for the treatment of osteoarthritis and cartilage rehabilitation | QUARK BIOTECH, INC. & SHIONOGI CO., LTD. | 2004-11-18 | — | — | US | claimed |
| US-20040220173-A1 | Novel heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor | AVENTIS PHARMACEUTICAL INC. (US) | 2004-11-04 | — | — | US | claimed |
| CN-1525818-A | Spermidine synthase inhibitors for the treatment of osteoarthritis and cartilage repair | ��ϣŵ | 2004-09-01 | — | — | CN | claimed |
| CN-1511828-A | Sufonic aniline derivatives and their medicinal use | �й������ž�����ҽѧ��ѧԺ����ҽ | 2004-07-14 | — | — | CN | claimed |
| US-6696454-B2 | ADMINISTERING AN INHIBITOR OF SPERMIDINE BIOSYNTHESIS; PREFERRED ARE DCHA (DICYCLOHEXYLAMINE), ADODATO, AND TRANS-4-METHYLCYCLOHEXYLAMINE (4MCHA) | QUARK BIOTECH, INC. | 2004-02-24 | — | — | US | claimed |
| EP-1362039-A1 | HETEROCYCLIC SUBSTITUTED CARBONYL DERIVATIVES AND THEIR USE AS DOPAMINE D3 RECEPTOR LIGANDS | Aventis Pharmaceuticals, Inc. (US) | 2003-11-19 | — | — | EP | claimed |
| EP-1357881-A2 | INHIBITORS OF SPERMIDINE SYNTHASE FOR THE TREATMENT OF OSTEOARTHRITIS AND CARTILAGE REHABILITATION | Quark Biotech, Inc. (US) | 2003-11-05 | — | — | EP | claimed |
| US-20020160978-A1 | Inhibitors of spermidine synthase for the treatment of osteoarthritis and cartilage rehabilitation | QUARK PHARMACEUTICALS, INC. | 2002-10-31 | — | — | US | claimed |
| WO-2002066446-A1 | HETEROCYCLIC SUBSTITUTED CARBONYL DERIVATIVES AND THEIR USE AS DOPAMINE D3 RECEPTOR LIGANDS | AVENTIS PHARMACEUTICALS INC. (US) | 2002-08-29 | — | — | WO | claimed |
| WO-2002058623-A2 | INHIBITORS OF SPERMIDINE SYNTHASE FOR THE TREATMENT OF OSTEOARTHRITIS AND CARTILAGE REHABILITATION | QUARK BIOTECH, INC. (US) | 2002-08-01 | — | — | WO | claimed |